HUM
28
-5
D
30
-7
JCI
50
3
PBI
66
7
VRTX
60
5
XEL
50
-3
HON
69
6
SEE
46
-3
MCO
81
7
NWL
60
-2
BLK
69
9
MCHP
64
21
A
48
9
NTRS
40
5
GIS
34
-15
HSIC
53
-3
RCL
76
-4
NWS
73
15
HSY
38
-6
SCHW
45
-8
HUM
28
-5
D
30
-7
JCI
50
3
PBI
66
7
VRTX
60
5
XEL
50
-3
HON
69
6
SEE
46
-3
MCO
81
7
NWL
60
-2
BLK
69
9
MCHP
64
21
A
48
9
NTRS
40
5
GIS
34
-15
HSIC
53
-3
RCL
76
-4
NWS
73
15
HSY
38
-6
SCHW
45
-8
Financhill
Back

Bristol-Myers Squibb 10K Form

Sell
46

BMY
Bristol-Myers Squibb

Last Price:
57.66
Seasonality Move:
1.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BMY News And Ratings

See the #1 stock for the next 7 days that we like better than BMY

BMY Financial Statistics

Sales & Book Value

Annual Sales: $45.01B
Cash Flow: $5.27B
Price / Cash Flow: 8.21
Annual Sales: $8.45
Price / Book: 6.61

Profitability

EPS (TTM): -3.59000
Net Income (TTM): $-7.26B
Gross Margin: $34.31B
Return on Equity: -33.18%
Return on Assets: -7.66%

Bristol-Myers Squibb Earnings Forecast

Key Bristol-Myers Squibb Financial Ratios

  • The Gross Profit Margin over the past 37 years for BMY is 76.24%.
  • The Selling, General & Administrative Expenses for BMY have been equal to 17.27% of Gross Profit Margin.
  • The Research & Development expenses have been 20.66% of Revenue.
  • The Interest Expense is 14.53% of Operating Income.
  • The Net Earning history of BMY is 17.83% of Total Revenues.
  • Per Share Earnings over the last 37 years have been positive in 19 years.

Bristol-Myers Squibb Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BMY
CUSIP: 110122
Website: bms.com

Debt

Debt-to-Equity Ratio: 2.9
Current Ratio: 1.24
Quick Ratio: 1.02

Price-to-Earnings

Trailing P/E Ratio: 14.47
Forward P/E Ratio: 7.9

BMY Technical Analysis vs Fundamental Analysis

Sell
46
Bristol-Myers Squibb (BMY) is a Sell

Is Bristol-Myers Squibb a Buy or a Sell?